A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia
Clinical trial NCT00316238 · COMPLETED
Trial details
- NCT number
- NCT00316238
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.